Interní Med. 2009; 11(7): 340-344

Highlights in diagnostics and management of rheumatoid arthritis

doc. MUDr. Radim Bečvář CSc, prof. MUDr. Karel Pavelka DrSc
Revmatologický ústav, Praha

Rheumatoid arthritis (RA) is an autoimmune disease of unknown aetiology characterized by presence of chronic synovitis which leads to

joint erosion formation. RA can start at any age and involves predominantly females (2 to 3-times). In aetiopathogenesis of RA hereditary

and external factors are involved, major role is played by so called shared epitope. Immune system is activated, tolerance is lost, and the

inflammation is localized into the joint tissues. Arthritis usually develops within weeks or months. At the same time morning stiffness

occurs with constitutional symptoms. RA may involve all joints except of distal interphalangeal joints. During the disease progression

destructions of cartilage and bone occur followed by deformities. The extraarticular manifestations include rheumatoid nodules, eye

and skin involvement, vasculitis, amyloidosis, rarely lung and heart involvement. Among the laboratory tests should be done following:

acute phase reactants, rheumatoid factor and antibodies to cyclic citrulinated peptide. Further, radiological examination is to be done,

the early morphological changes can be found using ultrasonography or MRI. In the management disease modifying drugs, glucocorticoids

and nonsteroidal antirheumatic drugs are used. So called biologicals represent novel therapeutic options. Complex therapy of

RA should also include nonpharmacological means like physiotherapy and joint surgery.

Keywords: arthritis, extraarticular manifestations, disease modifying drugs, biological therapy, nonsteroidal antirheumatic drugs.

Published: September 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bečvář R, Pavelka K. Highlights in diagnostics and management of rheumatoid arthritis. Interní Med. 2009;11(7):340-344.
Download citation

References

  1. American College of Rheumatology Subcommittee on Rheumatoid arthritis Guidelines. Guidelines for the management of rheumatoid arthritis 2002 Update. Arthritis Rheum 2002; 46: 328-346. Go to original source... Go to PubMed...
  2. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324. Go to original source... Go to PubMed...
  3. Bečvář R, Vencovský J, Němec P, Suchý D, Procházková L, Pavelka K. Doporučení České revmatologické společnosti pro léčbu revmatoidní artritidy. Účinnost a strategie léčby. Vnitř Lék 2008; 54: 84-99. Go to PubMed...
  4. Emery P, Breedveld FC, Lemmell EM, et al. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatol 2000; 39: 655-665. Go to original source... Go to PubMed...
  5. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004; 364: 263-269. Go to original source... Go to PubMed...
  6. Haagsma CJ, van Riel PLCM, de Jong AJ, van de Putte LB. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol 1997; 36: 1082-1088. Go to original source... Go to PubMed...
  7. Harris ED jr. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990; 322: 1277-1284. Go to original source... Go to PubMed...
  8. Hochberg MC. Adult and juvenile rheumatoid arthritis: current epidemiological concepts. Epidemiol Ref 1981; 3: 27-44. Go to original source... Go to PubMed...
  9. Klareskog L, Van der Heijde DM, De Jager JP, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004; 363: 675-881. Go to original source... Go to PubMed...
  10. Kremer JM, Phelps CT. Long-term prospective study of use of methotrexate in the treatment of rheumatoid arthritis - update after a mean of 90 months. Arthritis Rheum 1992; 35: 138-145. Go to original source... Go to PubMed...
  11. Maini R, StClair EW, Breedveld F, et al. Infliximab (chimeric anti-tumor necrosis factor alfa monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet 1999; 354: 1932-1939. Go to original source... Go to PubMed...
  12. Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007; 146 (11): 797-808. Go to original source... Go to PubMed...
  13. 46. O´Dell JR, Haire CE, Erikson N, et al. Treatment of rheumatoid arthritis with methotrexate alone, sulphasalazine and hydroxychloroquine or a combination of all three medications. N Engl J Med 1996; 334: 1287-1291.
  14. Pavelka K, Bečvář R, Olejárová M, Sainerová A. Revmatoidní artritida - Standardní postupy. Čes revmatol. 1999; 7 (Suppl 1): 4-8.
  15. Pavelka K, Rovenský J, Szilasiová A, Rovenská E, Buc M, Rybár I, Kopecký Š. Revmatoidní artritida. In: Pavelka K, Rovenský J eds. Klinická revmatologie. 1. vydání Praha: Galén 2003; 181-216.
  16. Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995; 333: 137-141. Go to original source... Go to PubMed...
  17. van der Heijde DM, van Leeuwen MA, van Riel PL, van de Putte LB. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 1995; 22 (9): 1792-1796. Go to PubMed...
  18. Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003; 48: 35-45. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.